Literature DB >> 17619977

Controllable release of salmon-calcitonin in injectable calcium phosphate cement modified by chitosan oligosaccharide and collagen polypeptide.

D X Li1, H S Fan, X D Zhu, Y F Tan, W Q Xiao, J Lu, Y M Xiao, J Y Chen, X D Zhang.   

Abstract

The aim of this research is to study the effect of the controlled releasing character of the salmon calcitonin (S-CT) loaded injectable calcium phosphate cement (CPC) modified by adding organic phase, chitosan oligosaccharide (CO) and collagen polypeptide (CP). The uniform design was used to determine the basic formulation with suitable injectable time for clinical application, and then the changes of the physical characters, the controlled releasing character of the modified CPC along with the ratio of the organic phase were also evaluated in vitro. The surface morphous of the modified CPC been implanted in the abdominal cavity or soaked into the serum of rat was also observed by scanning electron microscope (SEM). The result shows that a suitable formulation of modified CPC could be got, and the injectable time is 12 min, the compressive strength is 12 MPa, and the final setting time is 40 min. Comparing with the CPC without organic phase, the releasing rate of S-CT would increase along with the increase of the organic phase after 7th day. Therefore, a novel S-CT loaded bioactive injectable CPC for treating osteoporosis induced bone defect was obtained, and the release of the containing S-CT was controlled easily through adjusting the ratio of CO and CP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619977     DOI: 10.1007/s10856-007-3084-8

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  18 in total

1.  Noninvasive bone replacement with a new injectable calcium phosphate biomaterial.

Authors:  O Gauthier; I Khairoun; J Bosco; L Obadia; X Bourges; C Rau; D Magne; J M Bouler; E Aguado; G Daculsi; P Weiss
Journal:  J Biomed Mater Res A       Date:  2003-07-01       Impact factor: 4.396

2.  Some factors controlling the injectability of calcium phosphate bone cements.

Authors:  I Khairoun; M G Boltong; F C Driessens; J A Planell
Journal:  J Mater Sci Mater Med       Date:  1998-08       Impact factor: 3.896

3.  Calcitonin has direct effects on 3[H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast-line cells.

Authors:  J R Farley; J E Wergedal; S L Hall; S Herring; N M Tarbaux
Journal:  Calcif Tissue Int       Date:  1991-05       Impact factor: 4.333

4.  Chitosan oligosaccharide inhibits 203HgCl2-induced genotoxicity in mice: micronuclei occurrence and chromosomal aberration.

Authors:  Hyun Joong Yoon; Haeng Soon Park; Hee-Seung Bom; Young Bok Roh; Jong Se Kim; Young Ho Kim
Journal:  Arch Pharm Res       Date:  2005-09       Impact factor: 4.946

5.  Evaluation of an injectable calcium phosphate cement as an autograft substitute for transpedicular lumbar interbody fusion: a controlled, prospective study in the sheep model.

Authors:  T R Blattert; G Delling; A Weckbach
Journal:  Eur Spine J       Date:  2002-10-29       Impact factor: 3.134

Review 6.  Osteoporosis: a still increasing prevalence.

Authors:  Jean-Yves Reginster; Nansa Burlet
Journal:  Bone       Date:  2006-02       Impact factor: 4.398

7.  Injectable calcium phosphate bone cement Norian SRS for the treatment of intra-articular compression fractures of the distal radius in osteoporotic women.

Authors:  Robert Zimmermann; Markus Gabl; Martin Lutz; Peter Angermann; Martin Gschwentner; Sigurd Pechlaner
Journal:  Arch Orthop Trauma Surg       Date:  2003-01-11       Impact factor: 3.067

Review 8.  Calcium phosphate cements as bone drug delivery systems: a review.

Authors:  M P Ginebra; T Traykova; J A Planell
Journal:  J Control Release       Date:  2006-06-05       Impact factor: 9.776

9.  Calcitonin directly acts on mouse osteoblastic MC3T3-E1 cells to stimulate mRNA expression of c-fos, insulin-like growth factor-1 and osteoblastic phenotypes (type 1 collagen and osteocalcin).

Authors:  T Kobayashi; T Sugimoto; K Saijoh; M Fukase; K Chihara
Journal:  Biochem Biophys Res Commun       Date:  1994-03-15       Impact factor: 3.575

10.  Biomechanical evaluation of an injectable calcium phosphate cement for vertebroplasty.

Authors:  Tae-Hong Lim; Gregory T Brebach; Susan M Renner; Whoan-Jeang Kim; Jesse G Kim; Richard E Lee; Gunnar B J Andersson; Howard S An
Journal:  Spine (Phila Pa 1976)       Date:  2002-06-15       Impact factor: 3.468

View more
  4 in total

1.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

2.  Addition of sodium hyaluronate and the effect on performance of the injectable calcium phosphate cement.

Authors:  Dan Kai; Dongxiao Li; Xiangdong Zhu; Lei Zhang; Hongsong Fan; Xingdong Zhang
Journal:  J Mater Sci Mater Med       Date:  2009-03-17       Impact factor: 3.896

3.  Influence of polymeric additives on the cohesion and mechanical properties of calcium phosphate cements.

Authors:  Jie An; Joop G C Wolke; John A Jansen; Sander C G Leeuwenburgh
Journal:  J Mater Sci Mater Med       Date:  2016-01-19       Impact factor: 3.896

Review 4.  Injectable bone cements: What benefits the combination of calcium phosphates and bioactive glasses could bring?

Authors:  Öznur Demir-Oğuz; Aldo R Boccaccini; Dagnija Loca
Journal:  Bioact Mater       Date:  2022-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.